Terlipressin is an analogue of vasopressin used as a vasoactive drug in the management of hypotension. It has been found to be effective when norepinephrine does not help.
This report contains market size and forecasts of Terlipressin in global, including the following market information:
Global Terlipressin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Terlipressin Market Sales, 2017-2022, 2023-2028, (K Vials)
Global top five Terlipressin companies in 2021 (%)
The global Terlipressin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
5ml vial Injections Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Terlipressin include EVER Pharma, Hybio Pharmaceutical, Sun Pharmaceutical Industries Ltd., Shanghai Soho-Yiming Pharmaceuticals, Xi 'an langene biological technology, SGPharma, Maya Biotech and Hangzhou Huadi Group, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Terlipressin manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Terlipressin Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Vials)
Global Terlipressin Market Segment Percentages, by Type, 2021 (%)
5ml vial Injections
10mL vial Injections
Global Terlipressin Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Vials)
Global Terlipressin Market Segment Percentages, by Application, 2021 (%)
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Global Terlipressin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Vials)
Global Terlipressin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Terlipressin revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Terlipressin revenues share in global market, 2021 (%)
Key companies Terlipressin sales in global market, 2017-2022 (Estimated), (K Vials)
Key companies Terlipressin sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
EVER Pharma
Hybio Pharmaceutical
Sun Pharmaceutical Industries Ltd.
Shanghai Soho-Yiming Pharmaceuticals
Xi 'an langene biological technology
SGPharma
Maya Biotech
Hangzhou Huadi Group